Mn Services Vermogensbeheer B.V. Buys 1,321 Shares of McKesson Corporation $MCK

Key Points

• Mn Services Vermogensbeheer B.V. raised its stake in McKesson by 2.8%, buying 1,321 shares to hold 48,721 shares worth about $39.97 million at quarter-end.
• Wall Street coverage is positive with a consensus rating of “Moderate Buy” (13 Buys, 4 Holds) and a consensus target price of $960.93, as several firms have recently raised price targets.
• McKesson reported an EPS beat ($9.34 vs. $9.19) and revenue of $106.16 billion (up 11.4% year-over-year), set FY2026 guidance of $38.80–$39.20 EPS, and declared a $0.82 quarterly dividend (0.4% yield).

Mn Services Vermogensbeheer B.V. boosted its stake in McKesson Corporation (NYSE:MCK - Free Report) by 2.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 48,721 shares of the company's stock after buying an additional 1,321 shares during the quarter. Mn Services Vermogensbeheer B.V.'s holdings in McKesson were worth $39,965,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the stock. Brighton Jones LLC raised its stake in McKesson by 46.3% during the fourth quarter. Brighton Jones LLC now owns 2,523 shares of the company's stock worth $1,438,000 after acquiring an additional 798 shares in the last quarter. Caxton Associates LLP acquired a new stake in shares of McKesson in the 1st quarter valued at $233,000. Sivia Capital Partners LLC grew its holdings in shares of McKesson by 77.9% in the 2nd quarter. Sivia Capital Partners LLC now owns 685 shares of the company's stock worth $502,000 after purchasing an additional 300 shares during the last quarter. American Century Companies Inc. grew its holdings in shares of McKesson by 16.0% in the 2nd quarter. American Century Companies Inc. now owns 13,718 shares of the company's stock worth $10,052,000 after purchasing an additional 1,895 shares during the last quarter. Finally, Loomis Sayles & Co. L P acquired a new stake in shares of McKesson during the 2nd quarter worth about $39,000. 85.07% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

MCK has been the topic of a number of recent analyst reports. Leerink Partners restated an "outperform" rating and issued a $1,085.00 price target on shares of McKesson in a research report on Thursday, March 5th. Robert W. Baird set a $968.00 price objective on shares of McKesson in a report on Wednesday, January 14th. Barclays lifted their target price on shares of McKesson from $960.00 to $1,050.00 and gave the company an "overweight" rating in a research note on Wednesday, February 18th. Wells Fargo & Company boosted their target price on McKesson from $914.00 to $925.00 and gave the stock an "equal weight" rating in a report on Thursday, February 5th. Finally, Evercore restated an "outperform" rating on shares of McKesson in a research report on Thursday, March 5th. Thirteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $960.93.

Insider Transactions at McKesson

In other news, EVP Thomas L. Rodgers sold 276 shares of McKesson stock in a transaction on Monday, January 5th. The stock was sold at an average price of $816.18, for a total value of $225,265.68. Following the completion of the sale, the executive vice president directly owned 2,268 shares of the company's stock, valued at approximately $1,851,096.24. This trade represents a 10.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Leann B. Smith sold 190 shares of McKesson stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total value of $179,550.00. Following the completion of the sale, the executive vice president directly owned 2,989 shares of the company's stock, valued at $2,824,605. This trade represents a 5.98% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 3,868 shares of company stock worth $3,743,820 over the last ninety days. 0.08% of the stock is currently owned by insiders.

McKesson Stock Up 0.0%

Shares of NYSE MCK opened at $860.37 on Tuesday. McKesson Corporation has a 12-month low of $637.00 and a 12-month high of $999.00. The firm's 50-day simple moving average is $908.02 and its 200 day simple moving average is $841.69. The company has a market cap of $105.39 billion, a price-to-earnings ratio of 24.74, a price-to-earnings-growth ratio of 1.38 and a beta of 0.38.

McKesson (NYSE:MCK - Get Free Report) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, beating the consensus estimate of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The firm had revenue of $106.16 billion during the quarter, compared to analysts' expectations of $105.98 billion. During the same quarter last year, the company posted $8.03 EPS. The company's quarterly revenue was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, equities analysts expect that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be given a $0.82 dividend. This represents a $3.28 annualized dividend and a yield of 0.4%. The ex-dividend date is Monday, March 2nd. McKesson's payout ratio is 9.43%.

McKesson Company Profile

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.